ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $5,786,000 | -27.7% | 253,108 | -33.8% | 0.07% | -35.4% |
Q2 2020 | $8,004,000 | -58.1% | 382,400 | -50.7% | 0.11% | -50.9% |
Q3 2018 | $19,081,000 | +25.4% | 775,000 | 0.0% | 0.23% | +27.1% |
Q2 2018 | $15,213,000 | +4.7% | 775,000 | 0.0% | 0.18% | +0.6% |
Q1 2018 | $14,531,000 | – | 775,000 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |